Télécharger le livre :  Advances in Multiple Sclerosis and Experimental Demyelinating Diseases
Ajouter à ma liste d'envies
Controversy still exists regarding how early disease-modifying agents (DMA) should be commenced and whether all patients with relapsing-remitting MS should in fact be treated. To answer these questions, it is also important to know the natural history of the disease. MS...

Editeur : Springer
Parution : 2007-12-24
Collection : Current Topics in Microbiology and Immunology
PDF

147,69